![]() Financial Daily from THE HINDU group of publications Wednesday, Nov 12, 2003 |
|
|
|
|
|
Corporate
-
Research & Development Nicholas Piramal, Anna varsity team up for cancer research Our Bureau
Mumbai , Nov. 11 NICHOLAS Piramal India Ltd has inked an agreement with the Center of Biotechnology (CBT), Anna University in Chennai, for research in areas of cancer and inflammation. The exclusive R&D tie-up is designed to fast track the identification and development of plant extracts in the repository of the CBT for the treatment of rheumatoid arthritis and cancer. The Mumbai-based pharmaceutical company would have exclusive rights to commercialise any products coming out of the collaborative effort. NPIL's vast collection of natural products (over 6,000 plant extracts and 18,000 microbial strains) will also be evaluated by Dr Arun Balakrishnan, Director, CBT, against a variety of established targets, according to a press release. Nicholas Piramal has also established its fourth R&D centre on the outskirts of Chennai with an initial staff of 50 scientists.
Article E-Mail :: Comment :: Syndication
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | Home |
Copyright © 2003, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|